ID   BRAP_HUMAN              Reviewed;         592 AA.
AC   Q7Z569; B4DRM1; B9EGS8; O43238; O75341;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   10-MAY-2017, entry version 139.
DE   RecName: Full=BRCA1-associated protein;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:14724641};
DE   AltName: Full=BRAP2;
DE   AltName: Full=Impedes mitogenic signal propagation;
DE            Short=IMP;
DE   AltName: Full=RING finger protein 52;
DE   AltName: Full=RING-type E3 ubiquitin transferase BRAP2 {ECO:0000305};
DE   AltName: Full=Renal carcinoma antigen NY-REN-63;
GN   Name=BRAP {ECO:0000312|HGNC:HGNC:1099}; Synonyms=RNF52;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAP93638.1};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND INTERACTION WITH BRCA1.
RC   TISSUE=Fibroblast {ECO:0000269|PubMed:9497340};
RX   PubMed=9497340; DOI=10.1074/jbc.273.11.6183;
RA   Li S., Ku C.-Y., Farmer A.A., Cong Y.-S., Chen C.-F., Lee W.-H.;
RT   "Identification of a novel cytoplasmic protein that specifically binds
RT   to nuclear localization signal motifs.";
RL   J. Biol. Chem. 273:6183-6189(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   MUTAGENESIS OF CYS-264, AND INTERACTION WITH KSR1.
RC   TISSUE=T-cell {ECO:0000269|PubMed:14724641};
RX   PubMed=14724641; DOI=10.1038/nature02237;
RA   Matheny S.A., Chen C., Kortum R.L., Razidlo G.L., Lewis R.E.,
RA   White M.A.;
RT   "Ras regulates assembly of mitogenic signalling complexes through the
RT   effector protein IMP.";
RL   Nature 427:256-260(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 356-592 (ISOFORM 1), AND INTERACTION
RP   WITH DDB1.
RX   PubMed=10777491; DOI=10.1074/jbc.M000961200;
RA   Liu W., Nichols A.F., Graham J.A., Dualan R., Abbas A., Linn S.;
RT   "Nuclear transport of human DDB protein induced by ultraviolet
RT   light.";
RL   J. Biol. Chem. 275:21429-21434(2000).
RN   [8]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-97 AND SER-117,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Negatively regulates MAP kinase activation by limiting
CC       the formation of Raf/MEK complexes probably by inactivation of the
CC       KSR1 scaffold protein. Also acts as a Ras responsive E3 ubiquitin
CC       ligase that, on activation of Ras, is modified by auto-
CC       polyubiquitination resulting in the release of inhibition of
CC       Raf/MEK complex formation. May also act as a cytoplasmic retention
CC       protein with a role in regulating nuclear transport.
CC       {ECO:0000269|PubMed:14724641, ECO:0000303|PubMed:10777491}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:14724641}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with the nuclear localization signal of BRCA1
CC       and with the N-terminal of KSR1. The C-terminal portion of BCRA1
CC       interacts with DDB1. {ECO:0000269|PubMed:10777491,
CC       ECO:0000269|PubMed:14724641, ECO:0000269|PubMed:9497340}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-349900, EBI-349900;
CC       O75969:AKAP3; NbExp=2; IntAct=EBI-349900, EBI-9033101;
CC       P38398:BRCA1; NbExp=3; IntAct=EBI-349900, EBI-349905;
CC       P01112:HRAS; NbExp=3; IntAct=EBI-349900, EBI-350145;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9497340}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7Z569-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z569-2; Sequence=VSP_055881, VSP_055882;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in breast epithelial cell lines.
CC       {ECO:0000269|PubMed:9497340}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC24200.1; Type=Frameshift; Positions=556; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF035620; AAC24200.1; ALT_FRAME; mRNA.
DR   EMBL; AY332222; AAP93638.1; -; mRNA.
DR   EMBL; AK299326; BAG61333.1; -; mRNA.
DR   EMBL; AC002996; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC137055; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97972.1; -; Genomic_DNA.
DR   EMBL; BC136698; AAI36699.1; -; mRNA.
DR   EMBL; BC136699; AAI36700.1; -; mRNA.
DR   EMBL; AF035950; AAB88538.1; -; mRNA.
DR   CCDS; CCDS9154.1; -. [Q7Z569-1]
DR   RefSeq; NP_006759.3; NM_006768.4. [Q7Z569-1]
DR   UniGene; Hs.530940; -.
DR   ProteinModelPortal; Q7Z569; -.
DR   SMR; Q7Z569; -.
DR   BioGrid; 113912; 56.
DR   IntAct; Q7Z569; 42.
DR   MINT; MINT-1532927; -.
DR   STRING; 9606.ENSP00000403524; -.
DR   iPTMnet; Q7Z569; -.
DR   PhosphoSitePlus; Q7Z569; -.
DR   BioMuta; BRAP; -.
DR   DMDM; 296434410; -.
DR   EPD; Q7Z569; -.
DR   MaxQB; Q7Z569; -.
DR   PaxDb; Q7Z569; -.
DR   PeptideAtlas; Q7Z569; -.
DR   PRIDE; Q7Z569; -.
DR   Ensembl; ENST00000419234; ENSP00000403524; ENSG00000089234. [Q7Z569-1]
DR   GeneID; 8315; -.
DR   KEGG; hsa:8315; -.
DR   UCSC; uc001tsn.4; human. [Q7Z569-1]
DR   CTD; 8315; -.
DR   DisGeNET; 8315; -.
DR   GeneCards; BRAP; -.
DR   H-InvDB; HIX0036684; -.
DR   HGNC; HGNC:1099; BRAP.
DR   HPA; HPA040357; -.
DR   HPA; HPA058820; -.
DR   MIM; 604986; gene.
DR   neXtProt; NX_Q7Z569; -.
DR   OpenTargets; ENSG00000089234; -.
DR   PharmGKB; PA25410; -.
DR   eggNOG; KOG0804; Eukaryota.
DR   eggNOG; ENOG410XSS2; LUCA.
DR   GeneTree; ENSGT00500000044909; -.
DR   HOGENOM; HOG000190616; -.
DR   HOVERGEN; HBG050729; -.
DR   InParanoid; Q7Z569; -.
DR   KO; K10632; -.
DR   OMA; CLQRWED; -.
DR   OrthoDB; EOG091G07BQ; -.
DR   PhylomeDB; Q7Z569; -.
DR   TreeFam; TF313622; -.
DR   Reactome; R-HSA-5673000; RAF activation.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-HSA-6802946; Signaling by moderate kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802949; Signaling by RAS mutants.
DR   Reactome; R-HSA-6802955; Paradoxical activation of RAF signaling by kinase inactive BRAF.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; BRAP; human.
DR   GenomeRNAi; 8315; -.
DR   PRO; PR:Q7Z569; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000089234; -.
DR   CleanEx; HS_BRAP; -.
DR   ExpressionAtlas; Q7Z569; baseline and differential.
DR   Genevisible; Q7Z569; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008139; F:nuclear localization sequence binding; IDA:MGI.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:MGI.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0000165; P:MAPK cascade; IDA:MGI.
DR   GO; GO:0009968; P:negative regulation of signal transduction; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:FlyBase.
DR   GO; GO:0007265; P:Ras protein signal transduction; IDA:MGI.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 2.
DR   InterPro; IPR011422; BRAP2.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   Pfam; PF07576; BRAP2; 1.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   Pfam; PF02148; zf-UBP; 1.
DR   ProDom; PD017029; BRAP2; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00290; ZnF_UBP; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome; Cytoplasm;
KW   Metal-binding; Phosphoprotein; Reference proteome; Transferase;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    592       BRCA1-associated protein.
FT                                /FTId=PRO_0000055825.
FT   ZN_FING     264    304       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175, ECO:0000305}.
FT   ZN_FING     315    376       UBP-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00502}.
FT   COILED      429    537       {ECO:0000255}.
FT   MOD_RES      52     52       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      97     97       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     117    117       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     119    119       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   VAR_SEQ       1    141       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055881.
FT   VAR_SEQ     212    249       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055882.
FT   MUTAGEN     264    264       C->A: Loss of E3 ubiquitin-protein ligase
FT                                activity. {ECO:0000269|PubMed:14724641}.
FT   CONFLICT    186    186       E -> D (in Ref. 1; AAC24200 and 2;
FT                                AAP93638). {ECO:0000305}.
FT   CONFLICT    356    356       Y -> H (in Ref. 7; AAB88538).
FT                                {ECO:0000305}.
SQ   SEQUENCE   592 AA;  67305 MW;  70CFEAB560D1952C CRC64;
     MSVSLVVIRL ELAEHSPVPA GFGFSAAAGE MSDEEIKKTT LASAVACLEG KSPGEKVAII
     HQHLGRREMT DVIIETMKSN PDELKTTVEE RKSSEASPTA QRSKDHSKEC INAAPDSPSK
     QLPDQISFFS GNPSVEIVHG IMHLYKTNKM TSLKEDVRRS AMLCILTVPA AMTSHDLMKF
     VAPFNEVIEQ MKIIRDSTPN QYMVLIKFRA QADADSFYMT CNGRQFNSIE DDVCQLVYVE
     RAEVLKSEDG ASLPVMDLTE LPKCTVCLER MDESVNGILT TLCNHSFHSQ CLQRWDDTTC
     PVCRYCQTPE PVEENKCFEC GVQENLWICL ICGHIGCGRY VSRHAYKHFE ETQHTYAMQL
     TNHRVWDYAG DNYVHRLVAS KTDGKIVQYE CEGDTCQEEK IDALQLEYSY LLTSQLESQR
     IYWENKIVRI EKDTAEEINN MKTKFKETIE KCDNLEHKLN DLLKEKQSVE RKCTQLNTKV
     AKLTNELKEE QEMNKCLRAN QVLLQNKLKE EERVLKETCD QKDLQITEIQ EQLRDVMFYL
     ETQQKINHLP AETRQEIQEG QINIAMASAS SPASSGGSGK LPSRKGRSKR GK
//
